| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2021-01-06 06:45:59 UTC |
|---|
| Updated at | 2021-07-15 17:36:29 UTC |
|---|
| NP-MRD ID | NP0021484 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Minosaminomycin |
|---|
| Provided By | NPAtlas |
|---|
| Description | (2R)-2-({[(1R)-1-{[(2R,3R,5S,6S)-4-{[(2S,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]-C-hydroxycarbonimidoyl}-2-[(4S)-2-iminoimidazolidin-4-yl]ethyl]-C-hydroxycarbonimidoyl}amino)-4-methylpentanoic acid belongs to the class of organic compounds known as aminocyclitol glycosides. These are organic compounds containing an amicocyclitol moiety glycosidically linked to a carbohydrate moiety. There are two major classes of aminoglycosides containing a 2-streptamine core. They are called 4,5- and 4,6-disubstituted 2-deoxystreptamines. Minosaminomycin is found in Streptomyces and Streptomyces No. MA514-A1. Minosaminomycin was first documented in 1974 (PMID: 4843050). Based on a literature review very few articles have been published on (2R)-2-({[(1R)-1-{[(2R,3R,5S,6S)-4-{[(2S,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]-C-hydroxycarbonimidoyl}-2-[(4S)-2-iminoimidazolidin-4-yl]ethyl]-C-hydroxycarbonimidoyl}amino)-4-methylpentanoic acid. |
|---|
| Structure | [H]OC(=O)[C@]([H])(N([H])C(=O)N([H])[C@@]([H])(C(=O)N([H])[C@]1([H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[C@]2([H])O[C@]([H])(C([H])([H])[H])[C@@]([H])(N([H])[H])C([H])([H])[C@]2([H])N([H])[H])[C@@]([H])(O[H])[C@@]1([H])O[H])C([H])([H])[C@]1([H])N([H])C(=NC1([H])[H])N([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H] InChI=1S/C25H46N8O10/c1-8(2)4-14(22(39)40)32-25(41)31-13(5-10-7-29-24(28)30-10)21(38)33-15-16(34)18(36)20(19(37)17(15)35)43-23-12(27)6-11(26)9(3)42-23/h8-20,23,34-37H,4-7,26-27H2,1-3H3,(H,33,38)(H,39,40)(H3,28,29,30)(H2,31,32,41)/t9-,10+,11+,12+,13-,14-,15-,16-,17+,18-,19+,20+,23+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (2R)-2-({[(1R)-1-{[(2R,3R,5S,6S)-4-{[(2S,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]-C-hydroxycarbonimidoyl}-2-[(4S)-2-iminoimidazolidin-4-yl]ethyl]-C-hydroxycarbonimidoyl}amino)-4-methylpentanoate | Generator |
|
|---|
| Chemical Formula | C25H46N8O10 |
|---|
| Average Mass | 618.6890 Da |
|---|
| Monoisotopic Mass | 618.33369 Da |
|---|
| IUPAC Name | (2R)-2-({[(1R)-2-[(5S)-2-amino-4,5-dihydro-1H-imidazol-5-yl]-1-{[(1s,2R,3R,4r,5S,6S)-4-{[(2S,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]carbamoyl}ethyl]carbamoyl}amino)-4-methylpentanoic acid |
|---|
| Traditional Name | (2R)-2-({[(1R)-2-[(4S)-2-amino-4,5-dihydro-3H-imidazol-4-yl]-1-{[(1s,2R,3R,4r,5S,6S)-4-{[(2S,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]carbamoyl}ethyl]carbamoyl}amino)-4-methylpentanoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)C[C@@H](NC(=O)N[C@H](C[C@H]1CN=C(N)N1)C(=O)NC1[C@@H](O)[C@@H](O)C(O[C@@H]2O[C@H](C)[C@@H](N)C[C@@H]2N)[C@@H](O)[C@H]1O)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C25H46N8O10/c1-8(2)4-14(22(39)40)32-25(41)31-13(5-10-7-29-24(28)30-10)21(38)33-15-16(34)18(36)20(19(37)17(15)35)43-23-12(27)6-11(26)9(3)42-23/h8-20,23,34-37H,4-7,26-27H2,1-3H3,(H,33,38)(H,39,40)(H3,28,29,30)(H2,31,32,41)/t9-,10+,11+,12+,13-,14-,15?,16-,17+,18-,19+,20?,23+/m1/s1 |
|---|
| InChI Key | UDZJEGDQBWDMOF-BTPWPOGFSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Streptomyces | NPAtlas | | | Streptomyces No. MA514-A1 | Bacteria | |
|
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminocyclitol glycosides. These are organic compounds containing an amicocyclitol moiety glycosidically linked to a carbohydrate moiety. There are two major classes of aminoglycosides containing a 2-streptamine core. They are called 4,5- and 4,6-disubstituted 2-deoxystreptamines. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Aminocyclitol glycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Amino cyclitol glycoside
- Leucine or derivatives
- Hexose monosaccharide
- Alpha-amino acid or derivatives
- Methyl-branched fatty acid
- Hydroxy fatty acid
- Heterocyclic fatty acid
- Cyclohexanol
- Branched fatty acid
- Fatty acyl
- Fatty acid
- Oxane
- Monosaccharide
- Cyclitol or derivatives
- Imidazolidine
- Cyclic alcohol
- Amino acid
- Secondary alcohol
- Isourea
- Guanidine
- Amino acid or derivatives
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidamide
- Polyol
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Carboximidic acid derivative
- Carboximidic acid
- Acetal
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Primary aliphatic amine
- Imine
- Carbonyl group
- Amine
- Alcohol
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|